# | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
---|---|---|---|---|---|---|---|---|---|
1. | ALA634832 | A | Tested for biological half-life for enzyme inactivation at 100 nM concentration | 3 | assay format | Scientific Literature | |||
2. | ALA653794 | F | Tested for in vitro cytostatic activity against CEM cells | Homo sapiens | 10 | cell-based format | Scientific Literature | ||
3. | ALA677923 | F | Tested for in vitro cytostatic activity against murine mammary carcinoma (FM3A) | Mus musculus | 10 | cell-based format | Scientific Literature | ||
4. | ALA696744 | F | Effective dose required for plaque reduction in human cytomegalovirus (HCMV) was determined | Human betaherpesvirus 5 | 4 | organism-based format | Scientific Literature | ||
5. | ALA877710 | F | Effective dose required to reduce virus induced cytopathogenicity by Influenza A(H1N1,Fu 88) was determined | Influenza A virus | 3 | organism-based format | Scientific Literature | ||
6. | ALA696970 | F | Effective dose required to reduce virus induced cytopathogenicity by Influenza B(Fu 207) was determined | Influenza B virus | 4 | organism-based format | Scientific Literature | ||
7. | ALA696971 | F | Effective dose required to reduce virus induced cytopathogenicity by Influenza B(singapore) was determined | Influenza B virus | 3 | organism-based format | Scientific Literature | ||
8. | ALA704764 | F | Tested for in vitro cytostatic activity against murine leukemia L1210 | Mus musculus | 10 | cell-based format | Scientific Literature | ||
9. | ALA710083 | F | Tested for in vitro cytostatic activity against human lymphoblast Molt-4 (Clone8) | Homo sapiens | 8 | cell-based format | Scientific Literature | ||
10. | ALA756338 | B | Binding activity was evaluated on P3 purinoceptor-like protein from rat brain membranes by using [3H]NECA (40 nM). | Rattus norvegicus | 15 | assay format | Scientific Literature | ||
11. | ALA803715 | B | Tested for the percent enzyme activity remaining by inhibition of S-Adenosyl-L-homocysteine Hydrolase at 0.01 uM concentration | 9 | single protein format | Scientific Literature | |||
12. | ALA803716 | B | Tested for the percent enzyme activity remaining by inhibition of S-Adenosyl-L-homocysteine Hydrolase at 0.1 uM concentration | 9 | single protein format | Scientific Literature | |||
13. | ALA803717 | B | Tested for the percent enzyme activity remaining by inhibition of S-Adenosyl-L-homocysteine Hydrolase at 1 uM concentration | 9 | single protein format | Scientific Literature | |||
14. | ALA803718 | B | Tested for the percent enzyme activity remaining by inhibition of S-Adenosyl-L-homocysteine Hydrolase at 10 uM concentration | 9 | single protein format | Scientific Literature | |||
15. | ALA803719 | B | Tested for the percent enzyme activity remaining by inhibition of S-Adenosyl-L-homocysteine Hydrolase at 100 uM concentration | 9 | single protein format | Scientific Literature | |||
16. | ALA801946 | B | Tested for kinetic constant for the inhibition of recombinant human placental S-Adenosyl-L-homocysteine Hydrolase | 5 | assay format | Scientific Literature | |||
17. | ALA801952 | B | Tested for kinetic constant for the inactivation of recombinant human placental S-Adenosyl-L-homocysteine Hydrolase | 5 | assay format | Scientific Literature | |||
18. | ALA803316 | B | Evaluated for time-dependent and irreversible inhibitor of bovine S-adenosyl-L-homocysteine | Bos taurus | 1 | assay format | Scientific Literature | ||
19. | ALA816261 | F | Effective dose required for plaque reduction in vesicular stomatitis virus (VSV) was determined | Vesicular stomatitis virus | 5 | organism-based format | Scientific Literature | ||
20. | ALA847624 | B | Tested ratio of kinact to that of Ki | 5 | assay format | Scientific Literature |